OVID Ovid Therapeutics
- 0.964
- +0.006+0.61%
Ovid Therapeutics News
Ovid Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Bernstein Karen
Ovid Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Duncan Barbara Gayle
Ovid Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Friedman Bart
Ovid Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Fitzgerald Kevin Joseph
Ovid Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-EcoR1 Capital, LLC(0%),Oleg Nodelman(0%), etc.
Ovid Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BVF Partners L.P.(5.4%),BVF Inc.(5.4%), etc.
Ovid Therapeutics | 10-Q: Q3 2024 Earnings Report
Ovid Therapeutics | 8-K: Ovid Therapeutics Reports Business Updates and Third Quarter 2024 Financial Results
Ovid Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer ALEXANDER MARGARET A.
Ovid Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer ALEXANDER MARGARET A.
Ovid Therapeutics | 8-K: Current report
Ovid Therapeutics | 10-Q: Q2 2024 Earnings Report
Ovid Therapeutics | 8-K: Ovid Therapeutics Reports Business Updates and Second Quarter 2024 Financial Results
Ovid Therapeutics | 8-K: Current report
Ovid Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rona Jeffrey A
Ovid Therapeutics | 8-K: Current report
Ovid Therapeutics | 8-K: Current report
Ovid Therapeutics | 8-K: Current report
Ovid Therapeutics | 8-K: Current report
Ovid Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
No Data